Status:
UNKNOWN
Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies.
Lead Sponsor:
Peking University Third Hospital
Conditions:
Head and Neck Neoplasms
Eligibility:
All Genders
18-85 years
Brief Summary
This is a prospective single-arm cohort study to evaluate the accuracy and safety of three-dimensional printing co-planer template(3D-PCT) for computed tomography (CT)-guided neck and head biopsy .
Detailed Description
Tumors in head and neck region refer to those located above the clavicle, the upper boundary is the skull base, the posterior boundary is cervical vertebra, excluding brain spinal cord and other centr...
Eligibility Criteria
Inclusion
- (1) Ages 18 to 80; (2) KPS\>70 points, an estimated life expectancy of greater than 3 months; (3)Head and neck masses or nodules can be revealed by CT scan, MRI or ultrasonic examination; (4) Without taking drugs affecting coagulation and/or platelet aggregation are used; If used, the drug has been discontinued for a sufficient period of time (e.g. 1 week) ; (5) No serious or uncontrolled underlying diseases, clinical evaluation patients can tolerate puncture; (6) Planned biopsy with applicable puncture path; (7) With informed consent.
Exclusion
- (1)Biopsy needle insertion route impeded by skeletal structures and close to blood vessels which have high risks of puncture bleeding; (2)Poor organ function (e.g. poorly controlled high blood pressure); (3) Any contraindication of percutaneous head and neck biopsy; (4) Poor compliance, unable to complete coordination; (5) Participant who is considered inappropriate or unwilling to participate in this clinical trial for other reasons.
Key Trial Info
Start Date :
May 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 25 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05396183
Start Date
May 25 2022
End Date
March 25 2024
Last Update
May 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology of Peking university third hospital
Beijing, Beijing Municipality, China, 10010